Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription Articles published in Appl Radiat Isot Retrieve available abstracts of 46 articles: HTML format

Single Articles

October 2025
1. ZIMMERMAN BE, Denis-Bacelar AM, Rusnak J
   Needs for radionuclide metrology in the use of alpha-emitters for radionuclide-based therapy: Summary of an International Workshop.
   Appl Radiat Isot. 2025;224:111827.
   PubMed     Abstract available
   
   
   September 2025
2. LI H, Li X, Yang L, Chen L, et al
   Sequential synthesis of [(18)F]FDG and [(68)Ga]Ga-DOTA-TATE on the AllinOne radiosynthesizer: A fully automated dual-radionuclides protocol with single cassette and reagents loading.
   Appl Radiat Isot. 2025;223:111899.
   PubMed     Abstract available
   
   
   August 2025
3. AMADOR DIAZ V, Hall PM, Brown MJ, Vavere AL, et al
   Development and validation of a semi-automated [(13)N]Ammonia preparation system for clinical research.
   Appl Radiat Isot. 2025;222:111861.
   PubMed     Abstract available
   
   
   July 2025
4. WANG K, Zhu X, Wang Y, Xie J, et al
   Optimization of synthesis conditions of [(68)Ga]Ga-PSMA-D5 and its clinical application in prostate cancer.
   Appl Radiat Isot. 2025;221:111825.
   PubMed     Abstract available
   
   
   
5. EVANGELISTA VLO, Correia PD, Fuzato FQ, Maschio A, et al
   Simulation of the dose received by an occupationally exposed individual in the routine of a nuclear medicine service.
   Appl Radiat Isot. 2025;225:112021.
   PubMed     Abstract available
   
   
   June 2025
6. LI J, Li C, Zheng H, Yaddanapudi K, et al
   Biodistribution studies of (89)Zr-Labeled stem cell-derived exosomes using PET imaging.
   Appl Radiat Isot. 2025;225:112000.
   PubMed     Abstract available
   
   
   
7. MUNIR M, Forentin AM, Febrian MB, Fakih TM, et al
   Radiosynthesis of [(131)I]I-Hesperidin: Optimization, physicochemical profiling, and computational insights for targeted radiopharmaceuticals.
   Appl Radiat Isot. 2025;225:111977.
   PubMed     Abstract available
   
   
   May 2025
8. ANAGNOSTOU I, Michail C, Tseremoglou S, Valais I, et al
   Examining the effect of scatter radiation spread in LaCl(3):Ce and LaBr(3):Ce scintillators under nuclear medicine imaging exposure conditions.
   Appl Radiat Isot. 2025;224:111924.
   PubMed     Abstract available
   
   
   
9. SHEIKHZADEH P, Asami M, Mofrad MS, Abdolmaleki M, et al
   Organ doses, effective dose, and cancer risk estimation from whole-body CT scans in PET-CT imaging.
   Appl Radiat Isot. 2025;224:111892.
   PubMed     Abstract available
   
   
   
10. YANG X, Lv G, Peng Y, Liu Q, et al
    Synthesis and biological evaluation of a (68)Ga-labeled glucose derivative PET probe [(68)Ga]Ga-NOTA-SDG.
    Appl Radiat Isot. 2025;223:111893.
    PubMed     Abstract available
    
    
    April 2025
11. NISSIM S, Aviv O, Brandis M, Weissman L, et al
    Study of positron emission from (36)Cl.
    Appl Radiat Isot. 2025;222:111870.
    PubMed     Abstract available
    
    
    
12. STEINBERG PY, Bietti FT, Gomez N, Casale G, et al
    Densitometric measurement of (18)O content of (18)O-enriched water in relation to the production of (18)F-labelled radiopharmaceuticals.
    Appl Radiat Isot. 2025;222:111848.
    PubMed     Abstract available
    
    
    
13. SAPTIAMA I, Munir M, Qaira IS, Rindiyantono F, et al
    (99m)Tc radiolabeling of palm shell charcoal: A preliminary study for potential lung ventilation scintigraphy agent.
    Appl Radiat Isot. 2025;218:111689.
    PubMed     Abstract available
    
    
    
14. ALHUJAILI SF, Sulieman A, Alrowaili ZA, Alshabibi ASA, et al
    Radiation dose assessment and establishment of diagnostic reference levels for MDP Tc-99m bone scans: A multi-hospital study in Saudi Arabia.
    Appl Radiat Isot. 2025;218:111695.
    PubMed     Abstract available
    
    
    March 2025
15. KIM E, Lee C, Seo Y, Hong D, et al
    Synthesis and evaluation of a (68)Ga-labeled iodinated benzamide derivative as a PET imaging agent for malignant melanoma.
    Appl Radiat Isot. 2025;220:111791.
    PubMed     Abstract available
    
    
    
16. MORTHY P, Musarudin M, Shukor NSA, Said MA, et al
    Accuracy of (177)Lu activity quantification using MCNP5-Modeled SPECT imaging.
    Appl Radiat Isot. 2025;220:111786.
    PubMed     Abstract available
    
    
    
17. KHOSHYARI Z, Jahangir R, Miri-Hakimabad H, Mohammadi N, et al
    Monte Carlo-based estimation of patient absorbed dose in (99m)Tc-DMSA, -MAG3, and -DTPA SPECT imaging using the University of Florida (UF) phantoms.
    Appl Radiat Isot. 2025;220:111772.
    PubMed     Abstract available
    
    
    
18. YU HM, Lin KL, Yang CH, Chan CH, et al
    Development of an (18)F-labeled 5-aroylindole derivative for histone deacetylase 6 imaging in spinocerebellar ataxia.
    Appl Radiat Isot. 2025;217:111650.
    PubMed     Abstract available
    
    
    February 2025
19. A MOHYMEN A, Farag HI, Reda SM, Monem AS, et al
    Impact of reconstruction algorithms at different sphere-to-background ratios on PET quantification: A phantom study.
    Appl Radiat Isot. 2025;220:111761.
    PubMed     Abstract available
    
    
    
20. KOBAYASHI Y, Nakamura S, Takemori M, Nakaichi T, et al
    Comparison of dose distribution with and without reflecting heterogeneous boron distribution using (18)F-BPA positron emission tomography in boron neutron capture therapy.
    Appl Radiat Isot. 2025;219:111720.
    PubMed     Abstract available
    
    
    
21. NABAR SJ, Shet T, Malpani B, Hassan P, et al
    Technetium-99m-labeled stealth liposomes: A new Strategy to Identify metastasis in tumour model.
    Appl Radiat Isot. 2025;218:111709.
    PubMed     Abstract available
    
    
    
22. PATRA S, Ghosh S, Singh K, Chand Sharma S, et al
    Production, radiochemical separation and electrochemical concentration of No-carrier-added (52)Mn: An emerging PET radiometal.
    Appl Radiat Isot. 2025;218:111707.
    PubMed     Abstract available
    
    
    November 2024
23. ALOUFI KM, Gameraddin M, Alhazmi FH, Almazroui IS, et al
    Assessing radiation doses and proposing DRLs for nuclear medicine procedures for pediatric and adult patients in Madinah, Saudi Arabia.
    Appl Radiat Isot. 2024;215:111583.
    PubMed     Abstract available
    
    
    October 2024
24. SONDERGAARD U, Thomas KE, Soborg Pedersen K, Kranz M, et al
    Production of (67)Cu at a biomedical cyclotron via (70)Zn(p,alpha)(67)Cu reaction and its evaluation in a preclinical study using small animal SPECT/CT.
    Appl Radiat Isot. 2024;215:111551.
    PubMed     Abstract available
    
    
    
25. SANTOS JM, Balieiro LM, Santos RS, Matsuda MMN, et al
    Validation of chromatographic methods, TLC and HPLC, to quantify known radiochemical impurities and the radiochemical purity the radiopharmaceutical [(177)Lu]Lu-PSMA I&T.
    Appl Radiat Isot. 2024;215:111557.
    PubMed     Abstract available
    
    
    September 2024
26. SILINDIR-GUNAY M, Ozolmez N
    Adverse reactions to therapeutic radiopharmaceuticals.
    Appl Radiat Isot. 2024;214:111527.
    PubMed     Abstract available
    
    
    
27. KUMAR P, Shanbhag NC, Chaudhari P, Mohanty B, et al
    Radiolabeling and preclinical evaluation of technetium-99m labeled colistin.
    Appl Radiat Isot. 2024;214:111524.
    PubMed     Abstract available
    
    
    August 2024
28. VASIC V, Parodi K, Pinto M
    Evaluating an analytical prediction algorithm of positron emitter distributions in patient data for PET monitoring of carbon ion therapy: A simulation study.
    Appl Radiat Isot. 2024;213:111479.
    PubMed     Abstract available
    
    
    July 2024
29. SPAGNUOLO L, Capogni M, Fazio AA, De Felice P, et al
    National programme for the reliability of ionizing radiation measurements based on inter-laboratory comparisons (ILCs): ILC n degrees 2 'radiopharmaceutical activities'.
    Appl Radiat Isot. 2024;212:111449.
    PubMed     Abstract available
    
    
    
30. WANG M, Arkins CA, Zheng QH, Glick-Wilson B, et al
    Development and validation of a HPLC method for the determination of chemical and radiochemical purity of O-(2-[(18)F]fluoroethyl-l-tyrosine ([(18)F]FET)), a PET radiotracer for the imaging of brain tumor.
    Appl Radiat Isot. 2024;212:111444.
    PubMed     Abstract available
    
    
    June 2024
31. KANG KJ, Kim YG, Oh SJ, Won J, et al
    Determination of optimal injection dose in a small animal-dedicated positron emission tomography for non-human primate neurological studies.
    Appl Radiat Isot. 2024;211:111404.
    PubMed     Abstract available
    
    
    
32. HARPER R, Morim DR, Mehta D, Rosecker V, et al
    Optimised production of technetium-94m for PET imaging by proton-irradiation of phosphomolybdic acid in cyclotron liquid target.
    Appl Radiat Isot. 2024;210:111381.
    PubMed     Abstract available
    
    
    May 2024
33. ZOLGHADRI S, Mohammadpour-Ghazi F, Yousefnia H
    Preclinical studies and absorbed dose estimation of [(89)Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumors.
    Appl Radiat Isot. 2024;210:111379.
    PubMed     Abstract available
    
    
    
34. YAZDANI E, Asadi M, Geramifar P, Karamzade-Ziarati N, et al
    A step toward simplified dosimetry of radiopharmaceutical therapy via SPECT frame duration reduction.
    Appl Radiat Isot. 2024;210:111378.
    PubMed     Abstract available
    
    
    
35. VAVERE AL, Ghosh A, Amador Diaz V, Clay AJ, et al
    Automated radiosynthesis of [(18)F]DPA-714 on a commercially available IBA Synthera(R).
    Appl Radiat Isot. 2024;207:111257.
    PubMed     Abstract available
    
    
    April 2024
36. VIERA MA, Metidieri Cruz Malthez AL
    Radioprotection in the production of (18)F-FDG at Brazilian cyclotron facilities: A comparative study based on dosimetry.
    Appl Radiat Isot. 2024;206:111189.
    PubMed     Abstract available
    
    
    
37. DELLEPIANE G, Casolaro P, Gottstein A, Mateu I, et al
    (44)Sc production from enriched (47)TiO(2) targets with a medical cyclotron.
    Appl Radiat Isot. 2024;206:111220.
    PubMed     Abstract available
    
    
    March 2024
38. RANJBAR H, Bagheri R, Miremad SM
    Evaluation of (188)Re- IBA as a novel radiopharmaceutical for bone marrow ablation.
    Appl Radiat Isot. 2024;208:111300.
    PubMed     Abstract available
    
    
    February 2024
39. PENG L, Yang T, Zhang D, Wu R, et al
    Optimization and automation of the radiosynthesis of [(18)F]Lu-LuFL as a clinically useful PET ligand targeting FAP for tumor imaging.
    Appl Radiat Isot. 2024;207:111247.
    PubMed     Abstract available
    
    
    December 2023
40. ASHHAR Z, Ahmad Fadzil MF, Md Safee Z, Aziz F, et al
    Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron.
    Appl Radiat Isot. 2023;205:111161.
    PubMed     Abstract available
    
    
    
41. DEGUELDRE C, Findlay J, Cheneler D, Sardar S, et al
    Short life fission products extracted from molten salt reactor fuel for radiopharmaceutical applications.
    Appl Radiat Isot. 2023;205:111146.
    PubMed     Abstract available
    
    
    
42. MYBURGH PJ, Moore MD, Pathirannahel BL, Grace LR, et al
    Fully automated production of [(11)C]PiB for clinical use on Trasis-AllinOne synthesizer module.
    Appl Radiat Isot. 2023;202:111040.
    PubMed     Abstract available
    
    
    November 2023
43. KOVAN B
    The effects of kilovoltage (kV) and milliampere seconds (mAs) values for SPECT attenuation correction: An anthropomorphic phantom study.
    Appl Radiat Isot. 2023;204:111118.
    PubMed     Abstract available
    
    
    
44. OZOLMEZ N, Silindir-Gunay M, Volkan-Salanci B
    An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease.
    Appl Radiat Isot. 2023;203:111110.
    PubMed     Abstract available
    
    
    October 2023
45. SALAH H, Sulieman A, Alkhorayef M, Alkhybari E, et al
    Evaluation of personal dose equivalents during positron emission tomography and computed tomography imaging.
    Appl Radiat Isot. 2023;203:111078.
    PubMed     Abstract available
    
    
    
46. DE LA FUENTE-MENDOZA JE, Azorin-Vega EP, Mendoza-Nava HJ, Rodriguez-Martinez G, et al
    Estimation of the relative biological effectiveness (RBE) of the Lu-DOTA-iPSMA177
    Appl Radiat Isot. 2023;202:111065.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.